Nitti D - Search Results

1

Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

Lise M, Nitti D, Marchet A, Sahmoud T, Duez N, Fornasiero A, dos Santos JG, Labianca R, Lasser P, Gignoux M. Lise M, et al. Among authors: nitti d. Ann Surg Oncol. 1995 Nov;2(6):495-501. doi: 10.1007/BF02307082. Ann Surg Oncol. 1995. PMID: 8591079 Clinical Trial.

2

Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience.

Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Nitti D, et al. Ann Surg Oncol. 2003 Nov;10(9):1077-85. doi: 10.1245/aso.2003.03.520. Ann Surg Oncol. 2003. PMID: 14597447

3

Recent advances in conventional and molecular prognostic factors for gastric carcinoma.

Nitti D, Mocellin S, Marchet A, Pilati P, Lise M. Nitti D, et al. Surg Oncol Clin N Am. 2008 Jul;17(3):467-83, vii. doi: 10.1016/j.soc.2008.02.010. Surg Oncol Clin N Am. 2008. PMID: 18486878 Review.

4

Adjuvant FAM2 in resectable gastric cancer.

Lise M, Nitti D, Buyse M, Marchet A, Fiorentino M, Dos Santos JG, Duez N. Lise M, et al. Among authors: nitti d. Anticancer Res. 1989 Jul-Aug;9(4):1017-21. Anticancer Res. 1989. PMID: 2683987 Clinical Trial.

5

Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.

Lise M, Nitti D, Buyse M, Cartei G, Fornasiero A, Guimaraes dos Santos J, Duez N. Lise M, et al. Among authors: nitti d. Recent Results Cancer Res. 1988;110:36-43. doi: 10.1007/978-3-642-83293-2_5. Recent Results Cancer Res. 1988. PMID: 3043595 Clinical Trial. No abstract available.

6

Adjuvant therapy for colorectal cancer. The EORTC experience and a review of the literature.

Lise M, Gerard A, Nitti D, Zane D, Buyse M, Duez N, Arnaud JP, Metzger U. Lise M, et al. Among authors: nitti d. Dis Colon Rectum. 1987 Nov;30(11):847-54. doi: 10.1007/BF02555422. Dis Colon Rectum. 1987. PMID: 3315509 Review.

7

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.

Lise M, Nitti D, Marchet A, Sahmoud T, Buyse M, Duez N, Fiorentino M, Dos Santos JG, Labianca R, Rougier P, et al. Lise M, et al. Among authors: nitti d. J Clin Oncol. 1995 Nov;13(11):2757-63. doi: 10.1200/JCO.1995.13.11.2757. J Clin Oncol. 1995. PMID: 7595735 Clinical Trial.

8

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

Nitti D, Wils J, Sahmoud T, Curran D, Couvreur ML, Lise M, Rauschecker H, dos Santos JG, Stremmel W, Roelofsen F. Nitti D, et al. Eur J Cancer. 1997 Jul;33(8):1209-15. doi: 10.1016/s0959-8049(97)00052-x. Eur J Cancer. 1997. PMID: 9301444 Clinical Trial.

9

Resection of pulmonary metastases from colorectal carcinoma.

Zanella A, Marchet A, Mainente P, Nitti D, Lise M. Zanella A, et al. Among authors: nitti d. Eur J Surg Oncol. 1997 Oct;23(5):424-7. doi: 10.1016/s0748-7983(97)93723-9. Eur J Surg Oncol. 1997. PMID: 9393571

10

[Complementary treatment to surgery of gastric carcinoma: role of adjuvant and neoadjuvant chemotherapy].

Lise M, Nitti D, Marchet A, Tripodi M, Pilati P, Pasetto L. Lise M, et al. Among authors: nitti d. Chir Ital. 1997;49(3):35-9. Chir Ital. 1997. PMID: 9612650 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters